Skip to main content
Journal of Ayurveda and Integrative Medicine logoLink to Journal of Ayurveda and Integrative Medicine
. 2024 Mar 12;15(2):100887. doi: 10.1016/j.jaim.2024.100887

Effect of reconstituted, lyophilized cold aqueous extract of Aloe vera on human whole blood clotting time - A pilot study

Deena Susie Melenshia a,1,2, Soosai Manickam Amirtham a, Grace Rebekah b, Elizabeth Vinod a,c, Upasana Kachroo a,2,
PMCID: PMC10950739  PMID: 38479038

1. Introduction

Aloe vera is a pea-green coloured succulent plant that belongs to the Liliacea family and is found globally [1]. The gel and latex have healing effects, and thus the plant is well identified for its therapeutic role in the field of cosmetology [2]. Studies have also demonstrated the role of Aloe vera, in the treatment of conditions such as skin burns, pressure ulcers, stomatitis, periodontitis, indigestion and constipation, in addition to its known antioxidant, immunomodulatory and antidiabetic properties [[1], [2], [3]] (as noted in Table 1).

Table 1.

Showing literature demonstrating far-reaching actions and therapeutic roles of Aloe vera extracts and constituents.

S. No. Study Reference Study Type Composition Primary Findings
1. Probiotic/Antimicrobial action
Sun et al. [14] Animal: Mice Aloe polysaccharides Improvement in clinical symptoms of influenza
Panahi et al. [15] Human: Randomized trial Aloe syrup Reduced frequency of gastric reflux
2. Anti-inflammatory action
Li et al. [16] Animal: Mice Aloe emodin and rhein Reduced levels of Tumor necrosis factor, Nitric oxide and inflammatory interleukins
Werawatganon et al. [17] Animal: Mice Lyophilized Aloe gel Reduced levels of hepatic injury and malondialdehyde levels
3. Wound healing/Dermal Protection
Wahedi et al. [18] Animal: Mice Aloesin Inducing granulation tissue formation and accelerated wound closure
Hekmatpou et al. [19] Human: Randomized trial Pure Aloe gel Reduced incidence of pressure ulcers
4. Anti-cancer/Immunomodulatory action
Im et al. [20] Animal: Mice Processed Aloe gel Reduction in cyclophosphamide induced immunotoxicity
Liu et al. [21] Animal: Mice Aloe emodin Increased survival time and reduced cell migration
5. Anti-diabetic action
Noor et al. [22] Animal: Rats Crude Aloe extract Increase in pancreatic islet volume and Insulin secretion
6. Cardio-protective action
Sahin et al. [23] Animal: Rats Whole Aloe extract Reduced renal and pulmonary reperfusion ischemia injury

With regard to hemostatic effect, studies have shown mixed results wherein Aloe vera extract used intraperitoneally in Wistar rats caused prolongation of clotting time, while another study demonstrated reduction in clotting time when the extract was used with rat blood in an in-vitro set-up [4,5]. Although the anti-hemostatic effects seen with its use have been attributed to the presence of either salicylate mediated inhibition of prostaglandin synthesis, astringent zinc producing anti-platelet effect or polysaccharide mediated thrombo/fibrinolysis [4,6,7]; the discrepancy with regard to its effect on whole blood clotting time remains untested, with no literature reported in human subjects. In order to clarify the influence of the herb on human blood, this pilot was designed to analyse the effect of reconstituted lyophilized cold aqueous extract of Aloe vera on whole blood clotting time in human volunteers (in-vitro) to dissect the specifics of its hemostatic effect.

2. Materials and methods

2.1. Pilot particulars

The study was conducted in accordance with guidelines laid down in the declaration of Helsinki and Institutional Ethics Committee. The purpose of this in-vitro study was explained to all participants in detail, and after obtaining written, informed consent, 6 healthy, adult volunteers were recruited (Age: 30 ± 10 years; male = 3 and female = 3). Any volunteers with history of bleeding dyscrasias/coagulopathies or intake of medication causing deranged bleeding or clotting were excluded. Seven ml of venous blood was drawn from each individual to perform the whole blood clotting time.

2.2. Extract preparation

Around 250 g of fresh leaves of Aloe vera chinensis were taken and cleaned with 70% ethanol. Following removal of rind, clear parenchyma or gel within individual leaves was filleted into sections approximately 5 cm in dimension. Gel fillets were washed thoroughly with deionized water to remove latex and then ground into a liquid. This liquid obtained was then centrifuged at 2500 rpm for 5 min to remove unwanted fibers. Clear supernatant (approximately 150 ml) was added at a volume of 4ml/well to non-treated, sterile, 6-well culture plates and lyophilized at −72 °C for 48 h. The concentrated, freeze-dried extract was refrigerated at 4 °C until further use (Fig. 1).

Fig. 1.

Fig. 1

Shows the sequence of aqueous extract preparation ie. isolation of gel, centrifugation and obtaining supernatant of Aloe vera (A–C) D: Culture plates filled with extract being lyophilized; E: Lyophilized extract; F: Extract reconstituted with 200 μL of deionized water.

2.3. Reconstitution

To prepare the final dose, 15 mg freeze-dried powder of Aloe gel was resuspended with 200 μL deionized water for each experiment (minimum volume required for complete reconstitution of powder). Deionized water (200 μL) also served as vehicular control in the experiments.

2.4. Assessment of clotting time

Clotting time assessment was performed as per description provided by Ochei et al. [8] as a modification of Lee and White technique for estimation. In brief, two sterile syringes were used to draw blood. 1 ml of initially drawn blood in the first syringe was discarded to minimize the influence of tissue thromboplastin on the reading. Time was noted once the second syringe was introduced to collect blood. After collection of 6 ml of blood; 1 ml each was added to 6 glass test tubes (3 tubes per arm of study), which were pre-filled with control and test extract. [a. Reconstituted lyophilized Aloe vera, and b. Deionized water (Control)]. All tubes were kept in a 37 °C water-bath and left undisturbed for 5 min after collection of blood. At the end of 5 min, the first tube from each set was gently tipped to 45° to assess for clot formation. This was repeated at 30 s intervals till clotting was observed. After clotting in the first tube, time was noted and similar tilting was performed for the second and, consequently the third tube. The time recorded for clotting of the third tube was considered as the whole blood clotting time of the individual. (Additional purpose of the first two tubes was to intimate the clotting interval in the third tube, as agitation could accelerate the clotting process).

2.5. Statistical analysis

Clotting time data for each arm was taken, and results were expressed as Mean ± SD. Wavemetrics IgorPro software was utilized for graphical representation of data. Comparison between groups was performed using Mann Whitney U test, as stated for comparison of non-parametric sample data, by running the data on SPSS version 17.0. A P value of <0.05 was regarded as significant.

3. Results

It was observed that the mean clotting time with a) Control was 10.67 ± 0.98 min and b) Aloe vera was 18.67 ± 1.47 min. Clotting time observed with control was within the normal range (5–15 min), while with Aloe vera, there was an abnormal prolongation of clotting time which was also significantly longer when compared to values obtained with vehicular control (P=0.0052, Fig. 2). An additional assessment of the pH of reconstituted extract revealed a range of 6.7 ± 0.2, while assessment of blood sample pH revealed that addition of reconstituted extract did not acidify the blood sample.

Fig. 2.

Fig. 2

Shows graphical representation of Mean clotting time (in minutes) of human blood, as seen with addition ofAloe vera extract vs. vehicular control. Statistical analysis done using Mann Whitney U Test. (**P < 0.01).

4. Discussion

Multiple studies have advocated healing properties of Aloe vera over the course of the past few decades [[9], [10], [11]]. Phytochemical analysis of aloe vera whole extract has yielded data on its constituents which include active molecules of high research interest, generally implicated for the therapeutic activity of aloe vera. These primarily include anthraquinones such as aloin, emodin and acemannan, which have documented effects on cellular proliferation, turnover and signalling(2). With regard to treatment of the gel extract, aloe vera extract preparation in the current study included lyophilization or freeze drying, which is a common methodology utilized to obtain quantifiable dry powder, which has a significantly longer shelf-life as compared to fresh whole extract or its constituents. This methodology was specifically selected as lyophilization results in relatively unaltered extraction of the product as opposed to plain evaporation or heat induced drying methods. It is important to note that any treatment of whole extract may have implications on the composition. Such alterations are also noted for lyophilization, with a study evidencing that, it is specifically the polysaccharides (namely acemannan and aloin), and to some extent flavonoids, that show partial distraction while the mineral content remains largely unchanged [12]. Since the plant is available globally, it has also found its way into multiple home remedies for common ailments. Literature has also hinted at the anticoagulant and anti-platelet nature of the gel as seen in animal studies or isolated case reports [4,5,7,13]. At present, no restrictions exist to sale and oral consumption of the juice or concentrate, therefore it is crucial to assess the safety of the extract at doses presently being consumed. In this pilot study, we observed a significant increase in the mean clotting time beyond the normal range, when Aloe vera extract was used. This increase was validated, as the vehicular control demonstrated a significantly lower time for clotting than Aloe vera. These results corroborate the findings of the study by Dapper et al. who also demonstrated similar effects while negating the report by Ramesh H. et al. who showed pro-coagulant effects in Wistar rats [4,5]. This is the first study where the effect of the lyophilized extract has been assessed utilizing human blood in vitro. With respect to the mechanism of action observed with the effects seen in this pilot, it may be speculated that variable presence of anthraquinones may be responsible for the change in clotting time. It has been observed that aloin and emodin cause a decrease in the levels of Interleukin (IL)- 1, 6 and Tumor Necrosis Factor (TNF). Both TNF and IL-1, 6 are pro-inflammatory cytokines and present a pro-coagulant picture [2,13]. Their reduction could be the possible mechanism by which prolongation of clotting time occurs. It requires mention that with respect to the study findings, although Lee and White's test serves as a good screening method, an in-depth analysis of clotting time would require other parameters such as PT, aPTT estimation on samples where the pH of blood has been normalized before addition of the extracts. In addition to this, stringent analysis of herbal sub-components is required to identify active molecules responsible for the specific therapeutic action, in addition to investigating the pathway through which they predominantly exert their effect in vivo.

5. Conclusion

The observations of this pilot sound caution to the consumption of Aloe vera concentrate, especially in individuals with known bleeding tendencies or coagulopathies. Another important consideration could be the potential benefit that Aloe vera may provide in patients suffering from pro-coagulable states, by working as an adjunct to regular anti-coagulation therapy, an implication which warrants further exploration.

Funding source

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

CRediT authorship contribution statement

Deena Susie Melenshia: Methodology, Formal analysis, Data Curation, Writing – original draft. Soosai Manickam Amirtham: Methodology, Writing – review & editing. Grace Rebekah: Formal analysis, Writing – review & editing. Elizabeth Vinod: Methodology, Writing – review & editing. Upasana Kachroo: Conceptualization, Methodology, Formal analysis, Data curation, Supervision, Writing – original draft, Writing – review & editing.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgements

Authors would like to thank Department of Physiology, Christian Medical College, Vellore for infrastructural support, and all volunteers for agreeing to take part in this pilot.

Footnotes

Peer review under responsibility of Transdisciplinary University, Bangalore.

References

  • 1.Gao Y., Kuok K.I., Jin Y., Wang R. Biomedical applications of Aloe vera. Crit Rev Food Sci Nutr. 2019;59(sup1):S244–S256. doi: 10.1080/10408398.2018.1496320. [DOI] [PubMed] [Google Scholar]
  • 2.Sánchez M., González-Burgos E., Iglesias I., Gómez-Serranillos M.P. Pharmacological update properties of aloe vera and its major active constituents. Mol Basel Switz. 2020 Mar 13;25(6):1324. doi: 10.3390/molecules25061324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Liang J., Cui L., Li J., Guan S., Zhang K., Li J. Aloe vera: a medicinal plant used in skin wound healing. Tissue Eng Part B. 2021 Oct;27(5):455–474. doi: 10.1089/ten.TEB.2020.0236. [DOI] [PubMed] [Google Scholar]
  • 4.Dapper D.V., Achinike P.N., Gwotmut M.D. The effects of Aloe vera [gel] on clotting time, prothrombin time and plasma fibrinogen concentration in albino Wistar rats. P H Med J. 2007 Nov 23;2(1):56–60. [Google Scholar]
  • 5.R H., Jc H. An experimental study to test the haemostatic effect of Aloe vera. Int J Basic Clin Pharmacol. 2019 Mar 23;8(4):717–719. [Google Scholar]
  • 6.Fan J.J., Li C.H., Hu Y.J., Chen H., Yang F.Q. Comparative assessment of in vitro thrombolytic and fibrinolysis activity of four aloe species and analysis of their phenolic compounds by LC–M. South Afr J Bot. 2018 Nov 1;119:325–334. [Google Scholar]
  • 7.Lee A., Chui P.T., Aun C.S.T., Gin T., Lau A.S.C. Possible interaction between sevoflurane and Aloe vera. Ann Pharmacother. 2004 Oct;38(10):1651–1654. doi: 10.1345/aph.1E098. [DOI] [PubMed] [Google Scholar]
  • 8.Ochei J., Kolhatkar A. second ed. 2000. Medical laboratory science. Theory and practice; pp. 331–349. (Tata McGraw-hill publishing company limited New Delhi). [Google Scholar]
  • 9.Vogler B.K., Ernst E. Aloe vera: a systematic review of its clinical effectiveness. Br J Gen Pract J R Coll Gen Pract. 1999 Oct;49(447):823–828. [PMC free article] [PubMed] [Google Scholar]
  • 10.Hamman J.H. Composition and applications of Aloe vera leaf gel. Mol Basel Switz. 2008 Aug 8;13(8):1599–1616. doi: 10.3390/molecules13081599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hekmatpou D., Mehrabi F., Rahzani K., Aminiyan A. The effect of aloe vera clinical trials on prevention and healing of skin wound: a systematic review. Iran J Med Sci. 2019 Jan;44(1):1–9. [PMC free article] [PubMed] [Google Scholar]
  • 12.Krokida M., Pappa A., Agalioti M. Effect of drying on Aloe's functional components. Procedia Food Sci. 2011 Jan 1;1:1523–1527. [Google Scholar]
  • 13.Abebe W. Review of herbal medications with the potential to cause bleeding: dental implications, and risk prediction and prevention avenues. EPMA J. 2019 Jan 8;10(1):51–64. doi: 10.1007/s13167-018-0158-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Sun Z., Yu C., Wang W., Yu G., Zhang T., Zhang L., et al. Aloe polysaccharides inhibit influenza A virus infection—a promising natural anti-flu drug. Front Microbiol. 2018 Sep 27;9:2338. doi: 10.3389/fmicb.2018.02338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Panahi Y., Khedmat H., Valizadegan G., Mohtashami R., Sahebkar A. Efficacy and safety of Aloe vera syrup for the treatment of gastroesophageal reflux disease: a pilot randomized positive-controlled trial. J Tradit Chin Med Chung Tsa Chih Ying Wen Pan. 2015 Dec;35(6):632–636. doi: 10.1016/s0254-6272(15)30151-5. [DOI] [PubMed] [Google Scholar]
  • 16.Li C.Y., Suzuki K., Hung Y.L., Yang M.S., Yu C.P., Lin S.P., et al. Aloe metabolites prevent LPS-induced sepsis and inflammatory response by inhibiting mitogen-activated protein kinase activation. Am J Chin Med. 2017;45(4):847–861. doi: 10.1142/S0192415X17500458. [DOI] [PubMed] [Google Scholar]
  • 17.Werawatganon D., Linlawan S., Thanapirom K., Somanawat K., Klaikeaw N., Rerknimitr R., et al. Aloe vera attenuated liver injury in mice with acetaminophen-induced hepatitis. BMC Compl Alternative Med. 2014 Jul 8;14:229. doi: 10.1186/1472-6882-14-229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Wahedi H.M., Jeong M., Chae J.K., Do S.G., Yoon H., Kim S.Y. Aloesin from Aloe vera accelerates skin wound healing by modulating MAPK/Rho and Smad signaling pathways in vitro and in vivo. Phytomedicine Int J Phytother Phytopharm. 2017 May 15;28:19–26. doi: 10.1016/j.phymed.2017.02.005. [DOI] [PubMed] [Google Scholar]
  • 19.Hekmatpou D., Mehrabi F., Rahzani K., Aminiyan A. The effect of Aloe Vera gel on prevention of pressure ulcers in patients hospitalized in the orthopedic wards: a randomized triple-blind clinical trial. BMC Compl Alternative Med. 2018 Sep 29;18(1):264. doi: 10.1186/s12906-018-2326-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Im S.A., Kim K.H., Kim H.S., Lee K.H., Shin E., Do S.G., et al. Processed aloe vera gel ameliorates cyclophosphamide-induced immunotoxicity. Int J Mol Sci. 2014 Nov;15(11):19342–19354. doi: 10.3390/ijms151119342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.qing Liu Y., song Meng P., chao Zhang H., Liu X., Wang M xi, wu Cao W., et al. Inhibitory effect of aloe emodin mediated photodynamic therapy on human oral mucosa carcinoma in vitro and in vivo. Biomed Pharmacother. 2018 Jan 1;97:697–707. doi: 10.1016/j.biopha.2017.10.080. [DOI] [PubMed] [Google Scholar]
  • 22.Noor A., Gunasekaran S., Vijayalakshmi M.A. Improvement of insulin secretion and pancreatic β-cell function in streptozotocin-induced diabetic rats treated with aloe vera extract. Pharmacogn Res. 2017 Dec;9(Suppl 1):S99–S104. doi: 10.4103/pr.pr_75_17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Sahin H., Yener A.U., Karaboga I., Sehitoglu M.H., Dogu T., Altinisik H.B., et al. Protective effect of gel form of gastric gavage applicated aloe vera on ischemia reperfusion injury in renal and lung tissue. Cell Mol Biol Noisy--Gd Fr. 2017 Dec 30;63(12):34–39. doi: 10.14715/cmb/2017.63.12.9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Ayurveda and Integrative Medicine are provided here courtesy of Elsevier

RESOURCES